Evidence map›Paper›PMID 40188106›Full record

ArticleScientific reports2025

Identification of patients at risk for pancreatic cancer in a 3-year timeframe based on machine learning algorithms.

Weicheng Zhu, Long Chen, Yindalon Aphinyanaphongs, Fay Kastrinos, Diane M Simeone, Mark Pochapin, Cody Stender, Narges Razavian, Tamas A Gonda

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Weicheng ZhuCenter for Data Science, New York University, New York, NY, USA.
Long ChenCenter for Data Science, New York University, New York, NY, USA.
Yindalon AphinyanaphongsDepartment of Population Health, New York University Grossman School of Medicine, 227 East 30th Street, 6th Floor, New York, NY, 10016, USA.
Fay KastrinosDepartment of Medicine, Division of Digestive and Liver Diseases, Columbia University Irving Medical Center, New York, NY, USA.
Diane M SimeoneMoores Cancer Center, UC San Diego Health, San Diego, CA, USA.
Mark PochapinDivision of Gastroenterology and Hepatology, Department of Medicine, New York University, 240 East 38th Street, 23rd Floor, New York, NY, 10016, USA.
Cody StenderDepartment of Surgery, New York University, New York, NY, USA.
Narges Razavian *Department of Population Health, New York University Grossman School of Medicine, 227 East 30th Street, 6th Floor, New York, NY, 10016, USA. Narges.Razavian@nyulangone.org.
Tamas A Gonda *Division of Gastroenterology and Hepatology, Department of Medicine, New York University, 240 East 38th Street, 23rd Floor, New York, NY, 10016, USA. Tamas.Gonda@nyulangone.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Early detection of pancreatic cancer (PC) remains challenging largely due to the low population incidence and few known risk factors. However, screening in at-risk populations and detection of early cancer has the potential to significantly alter survival. In this study, we aim to develop a predictive model to identify patients at risk for developing new-onset PC at two and a half to three year time frame. We used the Electronic Health Records (EHR) of a large medical system from 2000 to 2021 (N = 537,410). The EHR data analyzed in this work consists of patients' demographic information, diagnosis records, and lab values, which are used to identify patients who were diagnosed with pancreatic cancer and the risk factors used in the machine learning algorithm for prediction. We identified 73 risk factors of pancreatic cancer with the Phenome-wide Association Study (PheWAS) on a matched case-control cohort. Based on them, we built a large-scale machine learning algorithm based on EHR. A temporally stratified validation based on patients not included in any stage of the training of the model was performed. This model showed an AUROC at 0.742 [0.727, 0.757] which was similar in both the general population and in a subset of the population who has had prior cross-sectional imaging. The rate of diagnosis of pancreatic cancer in those in the top 1 percentile of the risk score was 6 folds higher than the general population. Our model leverages data extracted from a 6-month window of time in the electronic health record to identify patients at nearly sixfold higher than baseline risk of developing pancreatic cancer 2.5-3 years from evaluation. This approach offers an opportunity to define an enriched population entirely based on static data, where current screening may be recommended.

Indexed as

Early Detection of CancerMachine LearningPancreatic NeoplasmsAgedAlgorithmsCase-Control StudiesElectronic Health RecordsFemaleHumansMaleMiddle AgedRisk AssessmentRisk FactorsMachine learningPancreasPancreatic cancerPredictive modelRisk factor

Identifiers

PMID40188106
PMCPMC11972345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.